Brief: Alzinova Signs LoI With Fujirebio
24/06/2026 08:07
BRIEF-Alzinova Signs LoI With Fujirebio June 24 (Reuters) - Alzinova AB ALZ.ST:
ALZINOVA SIGNS LETTER OF INTENT WITH FUJIREBIO REGARDING POTENTIAL COMMERCIALIZATION OF BLOOD-BASED ALZHEIMER'S DIAGNOSTIC TEST
POTENTIAL EXCLUSIVE LICENSE AND COMMERCIAL RIGHTS FOR FUJIREBIO SUBJECT TO VALIDATION DATA
Source text: ID:nMFN6nrzv2
Further company coverage: ALZ.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Alzinova AB
See all newsBrief: Alzinova's Board Resolves On Directed Issue Of Units
Brief: Alzinova Announces Preliminary Outcome Of The Rights Issue
Brief: Alzinova Broadens Shareholder Base With New Investor
Brief: Alzinova Resolves On Rights Issue Of SEK 51 Mln
Brief: Alzinova Q2 Loss After Financial Items At SEK 5.4 Million